Physician profile
James Butts
NPI 1164401360
$640.29
in general payments reported to CMS, 2019-2025
6 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $16.49 · 2022: $97.01 · 2023: $103 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $260.56 | 2019-2020 | |
| Atricure, INC. | $155.61 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Davol INC. | $97.01 | 2022 | |
| Zimmer Biomet Holdings, INC. | $90.33 | 2023 | Ribfix Blu Advantage |
| Mallinckrodt Enterprises LLC | $23.74 | 2019 | |
| Abbott Laboratories | $13.04 | 2023 | Epic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Butts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.